Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Change in Accured Expenses (2020 - 2025)

Stemtech's Change in Accured Expenses history spans 6 years, with the latest figure at -$709487.0 for Q3 2025.

  • For Q3 2025, Change in Accured Expenses changed N/A year-over-year to -$709487.0; the TTM value through Sep 2025 reached $250713.0, down 85.14%, while the annual FY2024 figure was $1.8 million, 89.07% up from the prior year.
  • Change in Accured Expenses for Q3 2025 was -$709487.0 at Stemtech, down from $347966.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.2 million in Q4 2021 and bottomed at -$1.1 million in Q4 2022.
  • The 5-year median for Change in Accured Expenses is $258941.5 (2021), against an average of $183406.4.
  • The largest annual shift saw Change in Accured Expenses surged 72670.51% in 2021 before it crashed 204.26% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at $1.2 million in 2021, then crashed by 189.56% to -$1.1 million in 2022, then soared by 111.82% to $128793.0 in 2023, then surged by 94.66% to $250713.0 in 2024, then plummeted by 382.99% to -$709487.0 in 2025.
  • Per Business Quant, the three most recent readings for STEK's Change in Accured Expenses are -$709487.0 (Q3 2025), $347966.0 (Q2 2025), and $361521.0 (Q1 2025).